Skip to content

Study on SLN Mapping and Clinicopathological Correlation of Cervical Combined with Cornual Injection versus Cervical Injection of Tracer in Early-stage Endometrial Carcinoma (EC)

Study on SLN Mapping and Clinicopathological Correlation of Cervical Combined with Cornual Injection versus Cervical Injection of Tracer in Early-stage Endometrial Carcinoma (EC)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120340
Enrollment
Unknown
Registered
2026-03-12
Start date
2025-01-03
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

Cervical Combined with Bilateral Cornual Injection Group:NA
Cervical Injection Group:NA

Sponsors

Jilin Provincial Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Clinical stage is endometrial carcinoma stage I-II (FIGO 2009), including well-differentiated, moderately differentiated, and poorly differentiated endometrioid carcinoma, serous carcinoma, and clear cell carcinoma; 2. Preoperative CT/enhanced CT imaging evaluation shows no enlarged lymph nodes.

Exclusion criteria

Exclusion criteria: 1. Advanced-stage endometrial carcinoma; 2. Intraoperative exploration reveals that the endometrial tumor lesions penetrate the uterine serosa, with pelvic/abdominal peritoneal metastasis; 3. Complicated with other surgical contraindications such as severe abnormalities in heart, liver, lung, or kidney function and/or other severe internal or surgical comorbidities, and those who cannot tolerate surgery, artificial pneumoperitoneum, or steep Trendelenburg position; 4. Uterine volume larger than that of a 3-month pregnancy, or those unable to completely remove the uterus transvaginally due to vaginal stenosis or other reasons.

Design outcomes

Primary

MeasureTime frame
Sentinel lymph node visualization rate;

Countries

China

Contacts

Public ContactJinxia Piao

Jilin Provincial Cancer Hospital

18243056930@163.com+86 135 7894 5886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 21, 2026